Skip to content

Study of injection of follicular fluid into uterine cavity on implantation rate in IVF cycle

Study of injection of follicular fluid into uterine cavity on implantation rate in IVF cycle

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015021713566N3
Enrollment
110
Registered
2015-05-29
Start date
2015-04-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility associated with anovulation

Interventions

Intervention 1: In the control group: Antagonist protocol GnRH will be used to stimulate ovulation, HCG may be used to seeing at least three follicles larger than 18 mm. After 34 to 36 hours will pun
Treatment - Drugs
In the control group: Antagonist protocol GnRH will be used to stimulate ovulation, HCG may be used to seeing at least three follicles larger than 18 mm. After 34 to 36 hours will puncture of ovarian
In the intervention group: Antagonist protocol GnRH will be used to stimulate ovulation, HCG may be used to seeing at least three follicles larger than 18 mm. After 34 to 36 hours will puncture of o

Sponsors

Vice chancellor for Research,Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients aged 20 to 40 years old; FSH levels below mIU / m l 10; BMI less than 35 kg /m2; transfer 2 or 3 embryos Grade A or B; Exclusion criteria: patients with endometriosis; hydrosalpinx; uterine anatomical abnormalities such as myoma; polyps; mullerian anomalies like two horns of the uterus; endocrine disorders such as thyroid disease; PCO and have a history of two or more implantation failure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chemical Pregnancy. Timepoint: Measure B-HCG Sixteen days after injection of HCG. Method of measurement: ?hCG test.;Clinical pregnancy ( gestational sac seen by viewing the fetal heart rate and fetal pole. Timepoint: After positive ßhCG. Method of measurement: Ultrasound.;Implantation rates. Timepoint: Two weeks after a positive pregnancy test. Method of measurement: Ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Kobra Hamdi

Tabriz University of Medical Sciences

hamdik@tbzmed.ac.ir; lahroudin@gmail.com+98 41 3556 9543

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026